C-Reactive Protein in Prediction of Ventriculoperitoneal Shunt-Related Infection in High-Risk Patients

被引:7
|
作者
Lolak, Sermkiat [1 ]
Bunyaratavej, Krishnapundha [1 ]
机构
[1] Chulalongkorn Univ, Fac Med, Dept Neurosurg, Bangkok 10330, Thailand
关键词
CEREBROSPINAL-FLUID; DEFINITIONS; MANAGEMENT; DRAINAGE;
D O I
10.1089/sur.2011.070
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: C-reactive protein (CRP) is an inflammatory marker believed to be of value in the early detection of meningitis. We evaluated its potential as a marker for prediction of shunt-related infection in high-risk subjects. Methods: We conducted a prospective pilot study in 26 ventriculoperitoneal shunt procedures; 18 of the patients were considered to be at high risk of infection at the time of shunt insertion. All patients were screened for other disease that could cause, an increase in CRP. Results: The serum CRP medians were 3.90 mg/L in the whole sample and 5.36 mg/L in the high-risk participants. All four shunt infections occurred in the high-risk group (22.2% of the group), three (75%) of which were in patients with meningitis. The logistic regression model showed that CRP concentrations above the cut-off value of >= 7 mg/L were related to shunt infection (p = 0.042). The receiving-operating characteristic curve revealed a cutoff point at >= 10.1 mg/L (sensitivity 0.75, 1 - specificity 0.18). The calculated area under the curve was 0.744. The sensitivity and specificity in the whole sample and high-risk group were not different (75% and 79%-80%, respectively). The positive post-test probability was 40% in the whole sample and 50% in the high-risk group. The negative post-test probability was 5% and 7%, respectively. Conclusion: Our data suggest that in a patient at high risk of shunt-related infection, the serum CRP concentration can be a valuable predictor of the risk of infection. Further studies in larger samples would be worthwhile.
引用
收藏
页码:192 / 195
页数:4
相关论文
共 50 条
  • [1] Headache and Shunt-Related Impact on Activities of Daily Life in Patients Growing Up with a Ventriculoperitoneal Shunt
    Beez, Thomas
    Bellstaedt, Lina
    Steiger, Hans-Jakob
    Sarikaya-Seiwert, Sevgi
    [J]. JOURNAL OF NEUROLOGICAL SURGERY PART A-CENTRAL EUROPEAN NEUROSURGERY, 2018, 79 (03) : 196 - 199
  • [2] High Sensitivity C-reactive Protein and Cardiovascular Risk Prediction
    Trpkovic, Andreja
    Stanimirovic, Julijana
    Resanovic, Ivana
    Otasevic, Petar
    Jevremovic, Danimir
    Djordje, Radak
    Isenovic, Esma R.
    [J]. CURRENT PHARMACEUTICAL ANALYSIS, 2015, 11 (01) : 60 - 65
  • [3] C-reactive protein risk prediction: low specificity, high sensitivity
    Koenig, W
    Pepys, MB
    [J]. ANNALS OF INTERNAL MEDICINE, 2002, 136 (07) : 550 - 552
  • [4] C-reactive protein and the MASCC risk index identify high-risk patients with febrile neutropenia and hematologic neoplasms
    Juan F. Combariza
    Milton Lombana
    Luis E. Pino
    Marcos Arango
    [J]. Supportive Care in Cancer, 2015, 23 : 1009 - 1013
  • [5] Comparability of C-reactive protein and highs-sensitive C-reactive protein for cardiovascular risk prediction
    Han, E.
    Fritzer-Szekeres, M.
    Gyongyosi, M.
    Bergler-Klein, J.
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2020, 132 : S231 - S232
  • [6] C-reactive protein and the MASCC risk index identify high-risk patients with febrile neutropenia and hematologic neoplasms
    Combariza, Juan F.
    Lombana, Milton
    Pino, Luis E.
    Arango, Marcos
    [J]. SUPPORTIVE CARE IN CANCER, 2015, 23 (04) : 1009 - 1013
  • [7] Comparison of High-Sensitivity C-Reactive Protein vs C-reactive Protein for Cardiovascular Risk Prediction in Chronic Cardiac Disease
    Han, Emilie
    Fritzer-Szekeres, Monika
    Szekeres, Thomas
    Gehrig, Teresa
    Gyongyosi, Mariann
    Bergler-Klein, Jutta
    [J]. JOURNAL OF APPLIED LABORATORY MEDICINE, 2022, 7 (06): : 1259 - 1271
  • [8] Effects of ezetimibe on markers of synthesis and absorption of cholesterol in high-risk patients with elevated C-reactive protein
    Barbosa, Simone P.
    Lins, Livia C.
    Fonseca, Francisco A.
    Matos, Livia N.
    Aguirre, Ana C.
    Bianco, Henrique T.
    Amaral, Jonatas B.
    Franca, Carolina N.
    Santana, Jose M.
    Izar, Maria C.
    [J]. LIFE SCIENCES, 2013, 92 (14-16) : 845 - 851
  • [9] Effects of ezetimibe on markers of synthesis and absorption of cholesterol in high-risk patients with elevated C-reactive protein
    Izar, M. C.
    Barbosa, S. P.
    Lins, L. C.
    Franca, C. N.
    De Matos, L. N.
    Aguirre, A. C.
    Bianco, H. T.
    Amaral, J. B.
    Fonseca, F. A.
    [J]. EUROPEAN HEART JOURNAL, 2013, 34 : 768 - 769
  • [10] C-reactive protein improves risk prediction in patients with acute coronary syndromes
    Schiele, Francois
    Meneveau, Nicolas
    Seronde, Marie France
    Chopard, Romain
    Descotes-Genon, Vincent
    Dutheil, Joanna
    Bassand, Jean-Pierre
    [J]. EUROPEAN HEART JOURNAL, 2010, 31 (03) : 290 - 297